COMPOSITIONS FOR TREATMENT OF DISORDERS OF THE OESOPHAGUS

The invention resides in a pharmaceutical composition and its use, the pharmaceutical composition comprising: a) 1 to 10 parts by weight of alginate, the alginate being a monovalent salt; b) 0.01 to 1.5 parts by weight of gum selected from xanthan gum, carageenan gum and mixtures thereof; and c) 0.0...

Full description

Saved in:
Bibliographic Details
Main Authors JOLLIFFE IAN GORDON, DETTMAR PETER WILLIAM, HAMPSON FRANK CHADWICK, DICKSON PAUL ANDREW
Format Patent
LanguageEnglish
Polish
Published 30.09.2008
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention resides in a pharmaceutical composition and its use, the pharmaceutical composition comprising: a) 1 to 10 parts by weight of alginate, the alginate being a monovalent salt; b) 0.01 to 1.5 parts by weight of gum selected from xanthan gum, carageenan gum and mixtures thereof; and c) 0.01 to 1.5 parts by weight of gum selected from a galactomannan, a glucomannan and mixtures thereof. The use is for the treatment and/or prevention of irritation and/or lesions in the oesophagus, diseases and/or irritations of the mouth, throat, pharynx and/or stomach and/or other diseases caused by or associated with reflux.
Bibliography:Application Number: PL20000351134